Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test

K-Number: K243400 · 2025-04-25

Decision Date2025-04-25
Product CodeQOF
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test is a medical device manufactured by Roche Molecular Systems, Inc.. It received FDA 510(k) clearance on 2025-04-25 under approval number K243400. The device is classified under product code QOF. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test?

cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test is a medical device that received FDA 510(k) clearance on 2025-04-25. It is manufactured by Roche Molecular Systems, Inc.. The 510(k) number is K243400.

When was cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test approved by the FDA?

cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test received FDA 510(k) clearance on 2025-04-25, under approval number K243400.

What company makes cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test?

cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test is manufactured by Roche Molecular Systems, Inc..

What is the FDA product code for cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test?

The FDA product code for cobas liat SARS-CoV-2 & Influenza A/B v2 nucleic acid test is QOF.

Other Devices by Roche Molecular Systems, Inc.

View all 47 devices →

Related Devices (Code: QOF)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.